Jilin Aodong Pharmaceutical Group Co., Ltd. H1 Income Climbs

India, Aug. 29 -- Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) released a profit for its first half that Increases, from last year

The company's bottom line totaled RMB2.050 billion, or RMB1.7486 per share. This compares with RMB1.281 billion, or RMB1.0915 per share, last year.

Excluding items, Jilin Aodong Pharmaceutical Group Co., Ltd. reported adjusted earnings of RMB2.228 billion or RMB1.9007 per share for the period.

The company's revenue for the period fell 8.4% to RMB1.031 billion from RMB1.126 billion last year.

Jilin Aodong Pharmaceutical Group Co., Ltd. earnings at a glance (GAAP) :

-Earnings: RMB2.050 Bln. vs. RMB1.281 Bln. last year.-EPS: RMB1.7486 vs. RMB1.0915 last year.-Revenue: RMB1.031 Bln vs. RMB1.126 Bln l...